{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:35:44Z","timestamp":1769837744170,"version":"3.49.0"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.maturitas.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T20:48:06Z","timestamp":1642711686000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Menopausal hormone therapy and melanoma risk in the Australian longitudinal study on women's health"],"prefix":"10.1016","volume":"160","author":[{"given":"Edoardo","family":"Botteri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie C.","family":"St\u00f8er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita D.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2022.01.004_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105182","article-title":"Postmenopausal exogenous hormone therapy and Melanoma risk in women: a systematic review and time-response meta-analysis","volume":"160","author":"Tang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.maturitas.2022.01.004_bib0002","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ijc.30878","article-title":"Menopausal hormone therapy and risk of melanoma: do estrogens and progestins have a different role?","volume":"141","author":"Botteri","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2022.01.004_bib0003","first-page":"12275","article-title":"In-vitro rescue and recovery studies of human melanoma (BLM) cell growth, adhesion and migration functions after treatment with progesterone","volume":"8","author":"Leder","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.maturitas.2022.01.004_bib0004","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.contraception.2009.03.005","article-title":"Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro","volume":"80","author":"Wiedemann","year":"2009","journal-title":"Contraception"},{"issue":"1547","key":"10.1016\/j.maturitas.2022.01.004_bib0005","article-title":"Cohort profile update: Australian longitudinal study on women\u2019s health","volume":"44","author":"Dobson","year":"2015","journal-title":"Int. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.maturitas.2022.01.004_bib0006","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1002\/ijc.32674","article-title":"Exogenous hormone use and cutaneous melanoma risk in women: the European prospective investigation into cancer and nutrition","volume":"146","author":"Cervenka","year":"2020","journal-title":"Int. J. Cancer"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512222000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512222000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:19:32Z","timestamp":1759915172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512222000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":6,"alternative-id":["S0378512222000160"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2022.01.004","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopausal hormone therapy and melanoma risk in the Australian longitudinal study on women's health","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}